BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$

Company Profile

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ had its IPO on under the ticker symbol BIBCL.

The company operates in the sector and industry. BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ has a staff strength of 0 employees.

Stock update

Shares of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ opened at ₹25.39 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹23 - ₹25.4, and closed at ₹23.76.

This is a -6.12% slip from the previous day's closing price.

A total volume of 80,446 shares were traded at the close of the day’s session.

In the last one week, shares of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ have slipped by -3.61%.

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$'s Key Ratios

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ has a market cap of ₹1.02 billion, indicating a price to book ratio of 1.2363 and a price to sales ratio of 1.5777.

In the last 12-months BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$’s revenue was ₹0 with a gross profit of ₹108.74 million and an EBITDA of ₹0. The EBITDA ratio measures BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q1, BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$’s profitability.

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ stock is trading at a EV to sales ratio of 2.5154 and a EV to EBITDA ratio of -20.7915. Its price to sales ratio in the trailing 12-months stood at 1.5777.

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹1.86 billion

Total Liabilities

₹914.41 million

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ ended 2024 with ₹1.86 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹1.86 billion while shareholder equity stood at ₹877.97 million.

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ ended 2024 with ₹0 in deferred long-term liabilities, ₹914.41 million in other current liabilities, in common stock, ₹-666293000.00 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹12.86 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$’s total current assets stands at ₹330.63 million while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹138.76 million compared to accounts payable of ₹4.82 million and inventory worth ₹14.29 million.

In 2024, BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹23.76

52-Week High

₹51.8

52-Week Low

₹20.5

Analyst Target Price

₹

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ stock is currently trading at ₹23.76 per share. It touched a 52-week high of ₹51.8 and a 52-week low of ₹51.8. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹23.04 and 200-day moving average was ₹25.16 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.